---
schema_version: "secwatch.filing_event.v1"
accession: "0001534120-26-000016"
form_type: "8-K"
ticker: "AVTX"
cik: "0001534120"
company_name: "Avalo Therapeutics, Inc."
filed_at: "2026-03-27T23:59:59+00:00"
generated_at: "2026-05-15T08:37:04.753981+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Two Avalo Therapeutics directors to not stand for re-election at 2026 Annual Meeting

## Summary
- Dr. Jonathan Goldman and Mitchell Chan will not stand for re-election to the Board at the 2026 Annual Meeting.
- They will continue to serve as board members until the 2026 Annual Meeting.
- Decisions are not due to any disagreement with the Company regarding operations, policies, or practices.
- The Board expressed gratitude for their service and contributions.

## SEC filing metadata
- accession: 0001534120-26-000016
- form_type: 8-K
- ticker: AVTX
- cik: 0001534120
- company_name: Avalo Therapeutics, Inc.
- filed_at: 2026-03-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534120/000153412026000016/0001534120-26-000016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534120/000153412026000016/avtx-20260323.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001534120-26-000016
- JSON: https://secwatch.observer/filing/0001534120-26-000016.json
- Plain text: https://secwatch.observer/filing/0001534120-26-000016.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.